GoodRx Holdings, Inc. (GDRX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $796.85M | +0.6% |
| 2024 | $792.32M | +5.6% |
| 2023 | $750.26M | -2.1% |
| 2022 | $766.55M | +2.8% |
| 2021 | $745.42M | +35.4% |
| 2020 | $550.70M | +41.9% |
| 2019 | $388.22M | +55.6% |
| 2018 | $249.52M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $796.85M | +0.6% |
| 2024 | $792.32M | +5.6% |
| 2023 | $750.26M | -2.1% |
| 2022 | $766.55M | +2.8% |
| 2021 | $745.42M | +35.4% |
| 2020 | $550.70M | +41.9% |
| 2019 | $388.22M | +55.6% |
| 2018 | $249.52M | — |